Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Allergan, Inc.    AGN

Allergan, Inc. operates as a global healthcare company.It engages in the developing and commercializing innovative specialty pharmaceutical, medical device and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity... 
02/08Earnings Release
More about the company
Latest news on ALLERGAN, INC.
07:21a ALLERGAN : To pay $15m penalty over merger
01/17 Allergan to pay $15 million over failing to disclose merger talks
01/17 ALLERGAN : and Gedeon Richter Announce Positive Phase III Results for Ulipristal..
01/16 ALLERGAN : Big pharma establishes new industry standards group
01/10 ALLERGAN : Enters Licensing Agreement with Assembly Biosciences to Obtain Worldw..
01/10 ASSEMBLY BIOSCIENCES (NASDAQ : ASMB) Files An 8-K Entry into a Material Definiti..
01/09 IRONWOOD PHARMACEUTICALS,INC. (NASDA : IRWD) Files An 8-K Results of Operations ..
01/09 ALLERGAN : continues to acquire companies with 2 more deals
01/08 ALLERGAN PLC (NYSE : AGN) Files An 8-K Departure of Directors or Certain Officer..
01/07 ALLERGAN : 11 Surprising Uses For Botox
More news
Sector news : Pharmaceuticals - NEC
01:40pDJELI LILLY AND : to Buy Migraine Drug Developer CoLucid Pharmaceuticals
12:08p Drugmakers in Davos shift focus to chronic diseases of poor
08:49aDJBayer Joins Jobs Parade -- WSJ
01:56aDJBAYER : Will Keep Monsanto Jobs in U.S., Trump Team Says -- 2nd Update
12:05aDJAllergan Admits to Disclosure Violations During Valeant Bid
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
2015 MANNKIND : A Head Pain Gain Or A Pocket-Book Drain?
2015 Tracking Dan Loeb's Third Point Portfolio - Q1 2015 Update
2015 Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2015 Update
2015 Time Warner Is A Buy - Cramer's Lightning Round (5/21/15)
2015 Tracking John Paulson's Paulson & Company Portfolio - Q1 2015 Update
Income Statement Evolution
More Financials
Ambrose Robert Douglas Bailey Chairman & President
Scott M. Whitcup Chief Scientific Officer & Executive VP-Research
Raymond H. Diradoorian Executive VP-Global Technical Operations
Maria Teresa Hilado Director
Joann Bradley Investor Relations Contact
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON-0.30%312 507
ROCHE HOLDING LTD.1.29%200 476
PFIZER INC.-1.29%194 551
NOVARTIS AG-2.70%185 185
MERCK & CO., INC.4.43%169 509
More Results